Artificial intelligence (AI)-powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of response to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC).

被引:0
|
作者
Lee, Hee Jin
Cho, Soo Yoon
Cho, Eun Yoon
Lim, Yoojoo
Cho, Soo Ick
Jung, Wonkyung
Song, Sanghoon
Kang, Mingu
Ryu, Jeongun
Ma, Minuk
Park, Seonwook
Paeng, Kyunghyun
Ock, Chan-Young
Song, Sang Yong
Gong, Gyungyub
机构
[1] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea
[2] Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[3] Sung kyunkwan Univ, Dept Pathol, Samsung Med Ctr, Sch Med, Seoul, South Korea
[4] Lunit Inc, Seoul, South Korea
[5] Samsung Med Ctr, Seoul, South Korea
[6] Univ Ulsan, Dept Pathol, Coll Med, Asan Med Ctr, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
595
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Artificial intelligence (AI) -powered spatial analysis of tumor-infiltrating lymphocytes (TILs) for prediction of prognosis in resectable pancreatic adenocarcinoma (PDAC)
    Lim, Yoojoo
    Choi, Jin Ho
    Kim, Hyemin
    Han, In Woong
    Song, Sanghoon
    Shin, Jiwon
    Song, Heon
    Park, Seonwook
    Pereira, Sergio
    Shin, Sang Hyun
    Heo, Jin Seok
    Lee, Kwang Hyuck
    Lee, Kyu Taek
    Lee, Jong Kyun
    Jang, Kee-Taek
    Ock, Chan-Young
    Park, Joo Kyung
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Tumor-infiltrating lymphocytes in triple negative breast cancer
    Zakhartseva, L. M.
    Yanovytska, M. O.
    [J]. PATHOLOGIA, 2020, (03): : 287 - 294
  • [33] Prognostic impact of tumor-infiltrating lymphocytes (TIL's) and stromal-infiltrating lymphocytes (SIL's) in triple-negative breast cancer.
    Sherwell-Cabello, Santiago
    Maffuz-Aziz, Antonio
    Camacho-Ramirez, Diego A.
    Bautista-Pina, Veronica
    Rios-Luna, Nina P.
    Labastida-Almendaro, Sonia
    Rodriguez-Cuevas, Sergio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [34] A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer
    Criscitiello, C.
    Bayar, M. A.
    Curigliano, G.
    Symmans, F. W.
    Desmedt, C.
    Bonnefoi, H.
    Sinn, B.
    Pruneri, G.
    Vicier, C.
    Pierga, J. Y.
    Denkert, C.
    Loibl, S.
    Sotiriou, C.
    Michiels, S.
    Andre, F.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (01) : 162 - 169
  • [35] Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response in triple-negative breast cancer: A systematic review and meta-analysis
    Sun, Hai-Kuan
    Jiang, Wen-Long
    Zhang, Shi-Lei
    Xu, Peng-Cheng
    Wei, Li-Min
    Liu, Jiang-Bo
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (07):
  • [36] Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Floris, Giuseppe
    Richard, Francois
    Hamy, Anne-Sophie
    Jongen, Lynn
    Wildiers, Hans
    Ardui, Jan
    Punie, Kevin
    Smeets, Ann
    Berteloot, Patrick
    Vergote, Ignace
    De Croze, Diane
    Meseure, Didier
    Salomon, Anne
    Lae, Marick
    Reyal, Fabien
    Biganzoli, Elia
    Neven, Patrick
    Desmedt, Christine
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (02) : 146 - 153
  • [37] Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization
    Sofia Gomez-Macias, Gabriela
    Molinar-Flores, Guillermo
    Lopez-Garcia, Carlos A.
    Santuario-Facio, Sandra
    Decanini-Arcaute, Horacio
    Valero-Elizondo, Javier
    Trevino-Alvarado, Victor
    Ortiz-Lopez, Rocio
    Dono, Antonio
    Esteban-Zubero, Eduardo
    Alatorre-Jimenez, Moises A.
    Villarreal Garza, Cynthia
    Pena-Curiel, Omar
    Cardona-Huerta, Servando
    [J]. ONCOLOGY LETTERS, 2020, 20 (05)
  • [38] Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes
    Asano, Yuka
    Kashiwagi, Shinichiro
    Goto, Wataru
    Takada, Koji
    Takahashi, Katsuyuki
    Hatano, Takaharu
    Takashima, Tsutomu
    Tomita, Shuhei
    Motomura, Hisashi
    Ohsawa, Masahiko
    Hirakawa, Kosei
    Ohira, Masaichi
    [J]. ANTICANCER RESEARCH, 2018, 38 (04) : 2311 - 2321